Open access · CC-BY
via OpenAlex
Inflammatory Biomarkers as Differential Predictors of Antidepressant Response
International Journal of Molecular Sciences · 2015 · ▲ 135 citations
Abstract
Although antidepressants are generally effective in the treatment of major depressive disorder (MDD), it can still take weeks before patients feel the full antidepressant effects. Despite the efficacy of standard treatments, approximately two-thirds of patients with MDD fail to respond to pharmacotherapy. Therefore, the identification of blood biomarkers that can predict the treatment response to antidepressants would be highly useful in order to improve this situation. This article discusses inflammatory molecules as predictive biomarkers for antidepressant responses to several classes of antidepressants, including the N-methyl-d-aspartate (NMDA) receptor antagonist ketamine.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms16047796
- Canonical
- link ↗
- Fetched
- 2026-07-28 MST
Cite this
APA
Hashimoto, K. (2015). Inflammatory Biomarkers as Differential Predictors of Antidepressant Response. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms16047796
Vancouver
Hashimoto K. Inflammatory Biomarkers as Differential Predictors of Antidepressant Response. International Journal of Molecular Sciences. 2015. doi:10.3390/ijms16047796.
BibTeX
@article{kenji2015Inflam,
title = {Inflammatory Biomarkers as Differential Predictors of Antidepressant Response},
author = {Kenji Hashimoto},
journal = {International Journal of Molecular Sciences},
year = {2015},
doi = {10.3390/ijms16047796},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in pharmacology 2026
Open access · OA
Neuroinflammation and treatment resistance in major depressive disorder.
Journal of Vascular Surgery 2013
Open access · OA
Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease
Dobri Kiprov 2022
Open access · US-GOV
A Comparative Randomized Placebo (Sham Pheresis) Controlled Clinical Trial To Evaluate The Effects Of Therapeutic Plasma Exchange (TPE) On Age Related Biomarkers And Epigenetics
University of Thessaly 2023
Open access · US-GOV
Frailty in Hip Fracture Patients Treated With Surgery; the Role of Simple Inflammatory Biomarkers. An Observational Study
Cell Metabolism 2014
Open access · OA
Rejuvenation: It’s in Our Blood
Disease Markers 2017
Open access · CC-BY